![Neal Gordon Simon](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Neal Gordon Simon
Oprichter bij Azevan Pharmaceuticals, Inc.
Actieve functies van Neal Gordon Simon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Azevan Pharmaceuticals, Inc.
![]() Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Directeur/Bestuurslid | 15-12-2010 | - |
Algemeen Directeur | 01-01-1999 | - | |
Oprichter | 01-01-1999 | - |
Loopbaan van Neal Gordon Simon
Eerdere bekende functies van Neal Gordon Simon
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
University of Strasbourg | Corporate Officer/Principal | 01-01-1996 | - |
Lehigh University | Corporate Officer/Principal | - | - |
Opleiding van Neal Gordon Simon
Rutgers State University of New Jersey | Doctorate Degree |
State University of New York at Binghamton | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Frankrijk | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoraal
Consumer Services | 5 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Azevan Pharmaceuticals, Inc.
![]() Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
- Beurs
- Insiders
- Neal Gordon Simon
- Ervaring